Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
GlobalData Clinical Trials Report Coverage 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Hypoglycemia to Metabolic Disorders Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Hypoglycemia to Metabolic Disorders Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Hypoglycemia Therapeutics Clinical Trials 28
Prominent Drugs 30
Latest Clinical Trials News on Hypoglycemia 31
Sep 21, 2017: JDRF Funds Zucara Therapeutics Approach to Preventing Hypoglycemia in People with Type 1 Diabetes 31
Clinical Trial Profile Snapshots 32
Appendix 134
Abbreviations 134
Definitions 134
Research Methodology 135
Secondary Research 135
About GlobalData 136
Contact Us 136
Source 136

List of Tables
Hypoglycemia Therapeutics, Global, Clinical Trials by Region, 2017* 6
Hypoglycemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Hypoglycemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
Hypoglycemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 9
Hypoglycemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 10
Hypoglycemia Therapeutics Clinical Trials, North America, Top Countries, 2017* 11
Hypoglycemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 12
Hypoglycemia Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 13
Proportion of Hypoglycemia to Metabolic Disorders Clinical Trials, G7 Countries (%), 2017* 14
Hypoglycemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
Hypoglycemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
Proportion of Hypoglycemia to Metabolic Disorders Clinical Trials, E7 Countries (%), 2017* 17
Hypoglycemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 18
Hypoglycemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 19
Hypoglycemia Therapeutics, Global, Clinical Trials by Phase, 2017* 20
Hypoglycemia Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 21
Hypoglycemia Therapeutics, Global, Clinical Trials by Trial Status, 2017* 22
Hypoglycemia Therapeutics Clinical Trials, Global, by End Point Status, 2017* 23
Hypoglycemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 24
Hypoglycemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 25
Hypoglycemia Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
Hypoglycemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 29
Hypoglycemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 30

List of Figures
Hypoglycemia Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
Hypoglycemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Hypoglycemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
Hypoglycemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 9
Hypoglycemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 10
Hypoglycemia Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 11
Hypoglycemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 12
Proportion of Hypoglycemia to Metabolic Disorders Clinical Trials, G7 Countries (%), 2017* 14
Hypoglycemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
Hypoglycemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
Proportion of Hypoglycemia to Metabolic Disorders Clinical Trials, E7 Countries (%), 2017* 17
Hypoglycemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 18
Hypoglycemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 19
Hypoglycemia Therapeutics, Global, Clinical Trials by Phase (%), 2017* 20
Hypoglycemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 21
Hypoglycemia Therapeutics, Global, Clinical Trials by Trial Status, 2017* 22
Hypoglycemia Therapeutics Clinical Trials, Global, by End Point Status, 2017* 23
Hypoglycemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 24
Hypoglycemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 25
Hypoglycemia Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 26
Hypoglycemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28
Hypoglycemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 30
GlobalData Methodology 135

Companies Mentioned
- XERIS Pharmaceuticals Inc
- Eli Lilly and Co
- Eiger BioPharmaceuticals Inc
- Merck & Co Inc
- Zealand Pharma AS
- XOMA Corp
- Novo A/S
- Novartis AG
- Zosano Pharma Corp
- Emissary International LLC